Results 31 to 40 of about 2,425 (160)

High performance liquid chromatographic method for simultaneous determination of fosinopril sodium and hydrochlorothiazide in tablets formulation [PDF]

open access: yes, 2006
Se ha desarrollado un método HPLC de fase inversa con detección de UV sencillo, específi co, exacto y preciso para la determinación de fosinopril sódico e hidroclorotiazida en formulaciones farmacéuticas. La solución de fármaco se preparó en fase móvil
Sutariya, V.B.   +2 more
core   +1 more source

Impact of Prior Angiotensin‐Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Delirium Incidence in ICU Patients: A Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims This investigation aimed at exploring the impact that the pre‐existing use of angiotensin‐converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) has on the incidence of delirium in patients within the intensive care unit (ICU).
Zhe Li   +4 more
wiley   +1 more source

Choosing antihypertensive drug for the treatment of hypertension

open access: yesМедицинский совет, 2013
The article tells about modern approaches to differentiated choice of antihypertensive drugs. The advantages and limitations of five key classes of antihypertensive medications are described.
O. D. Ostroumova, I. I. Kopchyonov
doaj   +1 more source

Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 4, Page 891-904, April 2026.
Limited evidence exists synthesizing the risk of acute kidney injury (AKI) associated with the concomitant administration of multiple nephrotoxic drugs, and even less examining the concept of nephrotoxic burden. The objective of this scoping review was to (1) identify definitions of nephrotoxic burden; (2) methods used to quantify (use of calculations)
Wafa Alatawi   +6 more
wiley   +1 more source

Treatment of Senile Hypertension The Fosinopril in Old Patients Study (FOPS) [PDF]

open access: yes, 1997
Data regarding the tolerance of ACE inhibitors in old age are sparse, despite this class of compound being regarded as one of the first-line agents for the treatment of hypertension.
W Vetter, Vetter, W
core   +1 more source

Chemerin Normal Function and Roles in Metabolic and Nonmetabolic Disorders: An Up‐To‐Date Comprehensive Review

open access: yesBiochemistry Research International, Volume 2026, Issue 1, 2026.
Chemerin (retinoic acid receptor responder 2; RARRES2) is a secreted chemoattractant/adipokine that is expressed mainly in white adipose tissue, liver, and placenta and becomes bioactive after C‐terminal proteolytic processing into isoforms with distinct activities. This review summarizes (i) chemerin biosynthesis, processing, receptors, and signaling (
Noha A. Ahmed   +7 more
wiley   +1 more source

The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension

open access: yes, 1990
The effect of the angiotensin converting enzyme (ACE) inhibitor fosinopril sodium on regional cerebral blood flow (rCBF) was investigated in 8 patients with moderate essential hypertension.
Paulson, O B   +5 more
core   +1 more source

On the effect of fosinopril in patients with diabetic neuropathy

open access: yes, 2003
Objective: Angiotensin converting enzyme (ACE) inhibitors have been shown to delay the progression of microvascular complications of diabetes mellitus. The effect of fosinopril on diabetic neuropathy over six months was investigated.
Vural Ö.   +3 more
core   +3 more sources

ACE inhibitors potential in correcting vessel wall anti-aggregation activity among patients with arterial hypertension and metabolic syndrome

open access: yesРоссийский кардиологический журнал, 2007
Captopril and fosinopril potential in correcting vascular wall anti-aggregation activity among patients with arterial hypertension (AH) and metabolic syndrome (MS) has been examined.
I. N. Medvedev   +2 more
doaj  

ACE inhibitor effects of brachial artery structure and function in patients with arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2012
Aim. To investigate the effects of an angiotensin-converting enzyme (ACE) inhibitor fosinopril on the structural and functional parameters of brachial arteries (BA) in patients with essential arterial hypertension (EAH). Material and methods.
L. V. Melnikova
doaj   +1 more source

Home - About - Disclaimer - Privacy